Protein Nanoparticles Modified with PDGF-B as a Novel Therapy After Acute Cerebral Infarction

Treatment options for cerebral infarction beyond the time window of reperfusion therapy are limited, and novel approaches are needed. PDGF-B is considered neuroprotective; however, it is difficult to administer at effective concentrations to infarct areas. Nanoparticles (NPs) are small and stable; t...

Descripción completa

Detalles Bibliográficos
Autores principales: Takagishi, Soh, Arimura, Koichi, Murata, Masaharu, Iwaki, Katsuma, Okuda, Tomohiro, Ido, Keisuke, Nishimura, Ataru, Narahara, Sayoko, Kawano, Takahito, Iihara, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society for Neuroscience 2021
Materias:
Research Article: New Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445038/
https://www.ncbi.nlm.nih.gov/pubmed/34462309
http://dx.doi.org/10.1523/ENEURO.0098-21.2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445038/
https://www.ncbi.nlm.nih.gov/pubmed/34462309
http://dx.doi.org/10.1523/ENEURO.0098-21.2021

Ejemplares similares